We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Byotrol Plc | LSE:BYOT | London | Ordinary Share | GB00B0999995 | ORDS 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.125 | 0.05 | 0.20 | 0.125 | 0.125 | 0.125 | 13,747 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Chemicals & Chem Preps, Nec | 4.59M | -1.69M | -0.0037 | -0.32 | 544.67k |
TIDMBYOT
RNS Number : 7465Y
Byotrol PLC
24 August 2018
24 August 2018
Byotrol plc
("Byotrol", the "Company" or the "Group")
Director Dealing
Byotrol plc, the AIM listed anti-microbial technology company, is pleased to announce that on 23 August 2018, John Langlands, Non-Executive Chairman of the Company purchased 500,000 ordinary shares of 0.25p each ("Ordinary Shares") at a price of 3.70p per Ordinary Share (the "Purchase").
Following the Purchase, Mr. Langlands has an interest in 4,600,000 Ordinary Shares representing approximately 1.07 per cent. of the total voting rights of the Company.
Enquiries:
Enquiries:
David Traynor - Chief Executive, Byotrol plc 01925 742 000
David Paton - Investor Relations 07714 190 474
finnCap Ltd 020 7220 0500 (Nominated Adviser & Broker)
Geoff Nash/Kate Bannatyne- Corporate Finance
Tim Redfern/Richard Chambers - Corporate Broking
The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of antimicrobial technologies, identifying, developing, formulating and commercialising cutting-edge antimicrobial solutions.
Our patented suite of technologies deliver powerful, broad-spectrum efficacy, optimised against commonly-occurring and industry-specific pathogens.
Founded in 2005, the Company seeks to develop and commercialise advanced antimicrobial technologies that create easier, safer and cleaner lives for everyone.
For more information, please go to www.byotrol.co.uk
Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):
1. Details of the person discharging managerial responsibilities / person closely associated ---- --------------------------------------------------------------- a) Name John Langlands ---- ------------------------------- ------------------------------ 2. Reason for the Notification ---- --------------------------------------------------------------- a) Position/status Non-Executive Chairman ---- ------------------------------- ------------------------------ b) Initial notification/Amendment Initial ---- ------------------------------- ------------------------------ 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ---- --------------------------------------------------------------- a) Name Byotrol Plc ---- ------------------------------- ------------------------------ b) LEI 213800AJMTSTIPA59A34 ---- ------------------------------- ------------------------------ 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ---- --------------------------------------------------------------- a) Description of ordinary shares of 0.25p each the Financial instrument, type of instrument ---- Identification GB00B0999995 code ---- ------------------------------- ------------------------------ b) Nature of the Purchase of Ordinary Shares transaction ---- ------------------------------- ------------------------------ c) Price(s) and Volume - 500,000 volume(s) Price - 3.70 pence ---- ------------------------------- ------------------------------ d) Aggregated information: See 4c) above ---- ------------------------------- ------------------------------ e) Date of the transaction 23 August 2018 ---- ------------------------------- ------------------------------ f) Place of the London Stock Exchange, AIM transaction Market (XLON) ---- ------------------------------- ------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHGMGZRVFFGRZM
(END) Dow Jones Newswires
August 24, 2018 02:00 ET (06:00 GMT)
1 Year Byotrol Chart |
1 Month Byotrol Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions